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Available online 29 January 2013A 49 years old female patient, works as an employee, living
at Suez, married & having 3 siblings, with no special habits of
medical importance. Patient is diabetic & hypertensive with
controlled blood sugar & blood pressure with no previous dia-
betic coma. Few years ago, the patient had a car accident with
subsequent post traumatic ﬁts that resolved spontaneously
with residual neurological deﬁcit.
One week before admission, the patient developed numb-
ness of the lips followed by vomiting, ﬂaccid paralysis & dis-
turbed level of consciousness occurring 3 h following the
intake of a ﬁsh meal.
The patient presented to the emergency room of Suez hos-
pital with disturbed level of consciousness of 1 week duration,
of sudden onset & progressive course. On examination, the pa-
tient was dyspnic, tachypnic with disturbed level of conscious-
ness. Chest auscultation showed bilateral basal coarse non-
ﬁxed crepitations. Neurological examination revealed aphasia,
stuperous with bilateral lost deep tendon reﬂex & bulbar cra-
nial nerve affection. Planter reﬂex was bilaterally equivocal.
The patient was transferred to the respiratory intensive care
unit (RICU) of Ain Shams Specialized Hospital. Upon presen-
tation to RICU, plain chest X ray was done (Fig. 1). The arte-
rial blood gases (ABGs) at the time of presentation showed
severe respiratory acidosis & this was followed by cardiac ar-
rest. An endotracheal tube was inserted & the patient was
put on mechanical ventilation for 5 days followed by successful
extubation. MRI brain was ordered & showed no abnormality
(Fig. 2).E-mail address: dr.imangalal@gmail.com
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vated erythrocyte sedimentation rate (ESR 39 mm/s).
After extubation, the patient developed an attack of dysp-
nea & cyanosis. ABGs showed alkalosis, hypocapnia & hy-
poxia. D-dimer was 4336 ng/ml (N: up to 500 ng/ml).
Ventilation/perfusion lung scan (V/Q scan) was done showing
pleural based segmental & subsegmental perfusion defects at
the anterior & posterior segments of the right upper lobe as
well as posterior basal segment of the lower lobe with normal
ventilation scan (Fig. 3). So, therapeutic anticoagulation was
started.
Follow-up chest X-ray was done (Fig. 4). ABGs follow-up
showed normal PO2 (86 mm Hg) & normal oxygen saturation
(SO2 98%).Final diagnosis
This is a case of acute respiratory failure secondary to respira-
tory muscle paralysis caused by neurotoxin tetrodotoxin
(TTX) poisoning with co-existing pulmonary embolism.Commentary
 Poisoning with the neurotoxin tetrodotoxin (TTX) occurs
after ingestion of various species of puffer ﬁsh. The ﬂesh
of the puffer ﬁsh (ie, fugu) is considered a delicacy in Japan.
It is prepared by chefs specially trained and certiﬁed by the
government to prepare the ﬂesh free of the toxic liver,
gonads, and skin. Despite these precautions, many cases
of tetrodotoxin poisoning are reported each year in patients
ingesting fugu (see Fig. 5).
 Poisonings usually occur after eating ﬁsh caught and pre-
pared by uncertiﬁed handlers.is. Production and hosting by Elsevier B.V.
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Figure 1 Chest radiograph on admission.
Figure 2 Brain CT-scan & MRI.
Figure 3 Ventilation/perfusion lung scan.
Figure 4 Follow-up chest radiograph before discharge.
Figure 5 Puffer ﬁsh.
230 I. Galal The toxic dose is not clear because puffer ﬁsh have different
concentrations of tetrodotoxin. A dose of 1–2 mg of puri-
ﬁed toxin can be lethal. Reported cases from the CDC have
documented toxicity with ingestion of as little as 1.4 ounces
of puffer ﬁsh.
 TTX also is found in the gastropod mollusc; in the eggs of
horseshoe crabs; in newts of the genus Taricha; in the skin
of Atelopid frogs; and in the skin and viscera of porcupine
ﬁsh, globeﬁsh, balloon ﬁsh, blowﬁsh, sunﬁsh, toadﬁsh,
blue-ringed octopus, and some species of salamanders. Puffer ﬁsh contain the potent neurotoxin tetrodotoxin.
TTX is thought to be synthesized by a bacterial or dinoﬂa-
gellate species associated with the puffer ﬁsh.
 The toxin is concentrated in the liver, gonads, and skin. The
level of toxicity is seasonal, and, in Japan, fugu is served
only from October through March.
 Tetrodotoxin is a heat-stable (except in alkaline environ-
ments) and water-soluble nonprotein.
Case report 231 TTX is a heterocyclic, small, organic molecule that acts
directly on the electrically active sodium channel in nerve
tissue. TTX blocks diffusion of sodium through the sodium
channel, preventing depolarization and propagation of
action potentials in nerve cells.
 All of the observed toxicity is secondary to the action
potential blockade. TTX acts on the central and the periph-
eral nervous systems (ie, autonomic, motor, sensory
nerves).
 TTX also stimulates the chemoreceptor trigger zone in the
medulla oblongata and depresses the respiratory & vasomo-
tor centers.
 Mortality rates approach 50%, even with modern support-
ive medical care. Patients who live through the acute intox-
ication (ie, ﬁrst 24 h) usually recover without residual
deﬁcits. Recovery takes days to occur.
 The ﬁrst symptoms occur 15 min to several hours post-
ingestion of TTX-containing food.
 Initial symptoms include lip & tongue paresthesias, fol-
lowed by facial & extremity paresthesias & numbness.
 Salivation, nausea, vomiting, & diarrhea with abdominal
pain develop early. Motor dysfunction with weakness, hypoventilation &
speech difﬁculties then develop. A rapid ascending paralysis
occurs over 4–24 h. Extremity paralysis precedes bulbar
paralysis, which is followed by respiratory muscle paralysis.
 Finally, cardiac dysfunction with hypotension & dysrhyth-
mias (bradycardia), central nervous system (CNS) dysfunc-
tion (eg, coma), & seizures develop. Patients with severe
toxicity may have deep coma, ﬁxed non-reactive pupils,
apnea, & loss of all brain stem reﬂexes.
 Death can occur within 4–6 h. Typically, death occurs from
respiratory muscle paralysis & respiratory failure.
 No drug has been shown to reverse the effects of TTX
poisoning.
 Treatment is symptomatic; removal of toxin from the intes-
tinal tract by the usual toxicologic modalities. The use of
nasogastric or orogastric lavage is theoretically beneﬁcial
but can be complicated by aspiration and damage to the
esophagus. The administration of activated charcoal is rec-
ommended for all symptomatic patients.
Anticholinesterase drugs (eg, neostigmine) have been pro-
posed as a treatment option but have not been tested adequately.
